Vadivarhe reports FY26 net loss of ₹163.77 lakh

1 min read     Updated on 29 May 2026, 01:03 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vadivarhe Speciality Chemicals approved audited financial results for FY26, reporting a net loss of ₹163.77 lakh versus a loss of ₹926.53 lakh in the previous year, while revenue rose to ₹4,578.03 lakh. The statutory auditors issued an unmodified opinion but highlighted material uncertainties regarding the company's ability to continue as a going concern due to eroded net worth. The board also appointed M/s. Yatin and Associates as internal auditors for FY27.

powered bylight_fuzz_icon
41317166

*this image is generated using AI for illustrative purposes only.

Vadivarhe Speciality Chemicals reported a net loss of ₹163.77 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹926.53 lakh in the previous year. The board approved the audited financial results for the half year and financial year ended March 31, 2026, during a meeting held on May 28, 2026. Revenue from operations for the year stood at ₹4,578.03 lakh, up from ₹3,790.53 lakh in FY25. For the half year ended March 31, 2026, the company posted a profit of ₹221.48 lakh.

S. R. Rahalkar & Associates, Statutory Auditors, issued an audit report with an unmodified opinion on the standalone financial results. However, the auditors included an emphasis of matter paragraph noting that the company has accumulated losses and its net worth has been fully eroded. The report states that current liabilities exceed current assets, indicating a material uncertainty about the company's ability to continue as a going concern. Management represented that confirmed orders in hand are expected to generate substantial cash flows and improve the financial position.

The board appointed M/s. Yatin and Associates, Chartered Accountants, as internal auditors for the financial year 2026-27. The firm is headed by CA Yatin Patwardhan and comprises a team of 24 professionals. The trading window for dealing in the company's securities, which closed on April 01, 2026, will reopen 48 hours after the declaration of the audited financial results.

Financial Performance

Particulars Year Ended 31/03/2026 (₹ in Lakhs) Year Ended 31/03/2025 (₹ in Lakhs)
Revenue from Operations 4,578.03 3,790.53
Total Revenue 4,640.63 3,817.45
Total Expenses 4,836.61 4,749.73
Profit/Loss for the Period (163.77) (926.53)
Basic EPS (₹) (1.28) (7.25)

Key Meeting Details

Agenda Item Details
Meeting Date May 28, 2026
Meeting Mode Video Conferencing / Other Audio-Visual Means
Financial Period Half year and Financial Year ended March 31, 2026
Trading Window Closure April 01, 2026

Historical Stock Returns for Vadivarhe Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.02%-0.59%+30.15%-24.40%+87.73%

What specific timeline does management anticipate for converting the confirmed orders into cash flow to resolve the going concern uncertainty?

Will the company need to raise additional equity or debt capital to bridge the gap between current liabilities and assets?

How will the appointment of the new internal auditor impact the company's cost control and financial compliance strategies in FY27?

Vadivarhe Speciality Chemicals
View Company Insights
View All News
like19
dislike

Vadivarhe Speciality Chemicals Completes Preferential Allotment of 22.17 Lakh Equity Shares at Rs 20 Per Share

1 min read     Updated on 25 Apr 2026, 11:04 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Vadivarhe Speciality Chemicals Limited completed a preferential allotment of 22,17,250 equity shares at Rs 20 per share to promoter Mr. Sunil Haripant Pophale on April 24, 2026. The allotment worth Rs 4,43,45,000 involved conversion of outstanding loan into equity shares, with each share carrying Rs 10 face value and Rs 10 premium. The transaction was approved by the Board of Directors and conducted in compliance with SEBI ICDR Regulations and Companies Act provisions.

powered bylight_fuzz_icon
38640866

*this image is generated using AI for illustrative purposes only.

Vadivarhe Speciality Chemicals Limited has successfully completed a preferential allotment of equity shares to its promoter, marking a significant corporate development. The Board of Directors approved the allotment through circulation on April 24, 2026, in compliance with regulatory requirements under SEBI Listing Regulations.

Allotment Details

The company has allotted 22,17,250 fully paid-up equity shares through preferential allotment to promoter Mr. Sunil Haripant Pophale. The shares were issued at Rs 20 per share, including a premium component.

Parameter: Details
Total Shares Allotted: 22,17,250
Issue Price: Rs 20 per share
Face Value: Rs 10 per share
Premium: Rs 10 per share
Total Issue Value: Rs 4,43,45,000
Allottee: Mr. Sunil Haripant Pophale
Category: Promoter

Transaction Structure

The preferential allotment represents a conversion of outstanding loan into equity shares. Mr. Sunil Haripant Pophale, identified as a promoter of the company, converted his existing loan of Rs 4,43,45,000 into equity participation through this allotment.

Aspect: Specification
Type of Consideration: Conversion of outstanding loan
Loan Amount Converted: Rs 4,43,45,000
Number of Investors: 1
Security Type: Equity Shares

Regulatory Compliance

The preferential issue was conducted in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and provisions of the Companies Act, 2013. The company has fulfilled its disclosure obligations under Regulation 30 of SEBI Listing Regulations.

The Board resolution was passed by circulation on April 24, 2026, with Company Secretary and Compliance Officer Manoj Kumar (Membership No. A56992) signing the regulatory intimation to the National Stock Exchange of India Limited. The disclosure includes comprehensive details as required under SEBI Master Circular dated January 30, 2026.

Corporate Impact

This preferential allotment strengthens the promoter's stake in Vadivarhe Speciality Chemicals Limited while converting debt into equity, potentially improving the company's debt-equity ratio. The transaction demonstrates the promoter's continued commitment to the company's growth and financial structure optimization.

Historical Stock Returns for Vadivarhe Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.02%-0.59%+30.15%-24.40%+87.73%

How will this debt-to-equity conversion impact Vadivarhe's credit rating and future borrowing capacity?

What strategic initiatives or expansion plans might the company pursue with its improved balance sheet structure?

Will this increased promoter stake influence the company's dividend policy or capital allocation strategy going forward?

Vadivarhe Speciality Chemicals
View Company Insights
View All News
like20
dislike

More News on Vadivarhe Speciality Chemicals

1 Year Returns:-24.40%